SCT and chronic pancreatitis: Secretin increases the diagnostic capabilities of MRCP in various pancreatic diseases and can be indicated in patients with known or suspected anatomic variants, sphincter of Oddi dysfunction, chronic pancreatitis, main pancreatic duct stenosis, cystic pancreatic lesions, pancreatic trauma, chronic asymptomatic hyperenzymaemia and post-operative conditions such as pancreato-jejunal anastomosis and pancreatic transplantation.